Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study

DOI Full Paper Access

92

Citations

26

References

2015

Year

Rosangela Invernizzi, Federica Quaglia, Catherine Klersy, Fabio Pagella, Federica Ornati, Francesco Chu, Elina Matti, Giuseppe Spinozzi, Sara Plumitallo, Pierangela Grignani,

The Lancet Haematology

Severe Recurrent EpistaxisHematologySurgeryBleeding DisorderMedicineHereditary Haemorrhagic Telangiectasia

References

	Year	Citations

Page 1